← Leaderboards
William J Martin
Indiana Univ-Purdue Univ At Indianapolis
$4,748,244
Attributed
$4,748,244
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$4,748,244 · 6
By mechanism
R01$3,316,022 · 3
R21$714,000 · 1
P01$688,222 · 1
R13$30,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Mitchell Goldman$10,867,864
- Chao-Hung Lee$3,081,846
- Homer L Twigg$9,155,869
- Christie M Orschell$7,516,916
- Mervin C. Yoder$10,075,746
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseNonhuman Therapy EvaluationAlveolar MacrophagesDisease /Disorder ModelLeukocyte Activation /TransformationGene TherapyHost Organism InteractionRespiratory EpitheliumLung InjuryBleomycinDna DamagePneumocystis PneumoniaTuberculosisScid MouseMycobacterium TuberculosisCytokinePneumocystis CariniiMicroorganism ImmunologyAntineoplasticsHiv InfectionsHistogenesisDiagnostic Respiratory LavageGenetic ManipulationGenetically Modified Animals
Grant awards (17)
Alveolar host defense to Pneumocytis carinii$345,375
R01 · FY2005 · AI
Alveolar host defense to Pneumocytis carinii$345,375
R01 · FY2004 · AI
Alveolar macrophage and mycobacteria$345,375
R01 · FY2004 · HL
Alveolar Tissuegenesis$241,875
R21 · FY2004 · HL
Alveolar macrophage and mycobacteria$345,375
R01 · FY2003 · HL
Alveolar host defense to Pneumocytis carinii$345,375
R01 · FY2003 · AI
Alveolar Tissuegenesis$241,875
R21 · FY2003 · HL
Management of COPD in the Pacific Rim$30,000
R13 · FY2003 · HL
Alveolar host defense to Pneumocytis carinii$385,595
R01 · FY2002 · AI
TUBERCULOSIS, HIV AND SURFACTANT APOPROTEINS$319,175
R01 · FY2002 · HL
Alveolar Tissuegenesis$230,250
R21 · FY2002 · HL
PROTECTION OF LUNG FROM CYTOTOXIC DRUGS$220,099
P01 · FY2002 · CA
Alveolar host defense to Pneumocytis carinii$321,606
R01 · FY2001 · AI
TUBERCULOSIS, HIV AND SURFACTANT APOPROTEINS$284,585
R01 · FY2001 · HL
PROTECTION OF LUNG FROM CYTOTOXIC DRUGS$220,099
P01 · FY2001 · CA
TUBERCULOSIS, HIV AND SURFACTANT APOPROTEINS$278,186
R01 · FY2000 · HL
PROTECTION OF LUNG FROM CYTOTOXIC DRUGS$248,024
P01 · FY2000 · CA